News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,576 Results
Type
Article (86489)
Company Profile (702)
Press Release (759385)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232680)
Career Advice (4127)
Deals (39720)
Drug Delivery (129)
Drug Development (90983)
Employer Resources (198)
FDA (18107)
Job Trends (17334)
News (396458)
Policy (39748)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56834)
ALS (100)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (158)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (306)
Cancer (2458)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (174)
Cell therapy (495)
Cervical cancer (21)
Clinical research (73422)
Collaboration (918)
Company closure (1)
Compensation (569)
Complete response letters (30)
COVID-19 (2868)
CRISPR (48)
C-suite (269)
Cystic fibrosis (108)
Data (2294)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (300)
Diagnostics (6924)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (102)
Earnings (96738)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130079)
Executive appointments (782)
FDA (19463)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (823)
Gene editing (121)
Generative AI (35)
Gene therapy (362)
GLP-1 (856)
Government (5163)
Grass and pollen (6)
Guidances (81)
Healthcare (20888)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17819)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (559)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (346)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (358)
MASH (76)
Medical device (14640)
Medtech (14645)
Mergers & acquisitions (22450)
Metabolic disorders (796)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2112)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (428)
Opinion (275)
Ovarian cancer (79)
Pain (102)
Pancreatic cancer (89)
Parkinson's disease (161)
Partnered (24)
Patents (254)
Patient recruitment (116)
Peanut (51)
People (65316)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22659)
Phase II (31875)
Phase III (24020)
Pipeline (1279)
Policy (174)
Postmarket research (3552)
Preclinical (10226)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (431)
Real estate (7392)
Recruiting (75)
Regulatory (26809)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (93)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (49)
The Weekly (82)
Vaccines (816)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (108)
Last 7 days (822)
Last 30 days (2930)
Last 365 days (35711)
2025 (12115)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50143)
Australia (8831)
California (6505)
Canada (2078)
China (567)
Colorado (284)
Connecticut (304)
Delaware (162)
Europe (115027)
Florida (947)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (635)
India (31)
Indiana (337)
Iowa (12)
Japan (172)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (973)
Massachusetts (4988)
Michigan (249)
Minnesota (425)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (66)
New Hampshire (70)
New Jersey (1837)
New Mexico (31)
New York (1844)
North Carolina (1139)
North Dakota (9)
Northern California (2781)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1434)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2412)
Tennessee (105)
Texas (981)
United States (24987)
Utah (194)
Virginia (173)
Washington D.C. (71)
Washington State (608)
West Virginia (3)
Wisconsin (71)
There are 846,576 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
May 6, 2025
·
1 min read
FDA
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and the accelerated approval of cancer drugs.
May 6, 2025
·
3 min read
·
Heather McKenzie
Press Releases
SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A
May 6, 2025
·
3 min read
Layoff Tracker
Mersana Axes 55% of Workforce To Help Extend Cash Runway
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 6, 2025
·
192 min read
·
BioSpace Editorial Staff
Press Releases
Vetter Prioritizes Continuity and Action in its Sustainability Efforts
May 6, 2025
·
1 min read
Manufacturing
Trump Orders FDA To Ease US Plant Expansion; Drops Hammer on Foreign Inspections
A new executive order from President Donald Trump aims to cut down the 5-to-10-year timeline to build new facilities while stepping up the rigor of inspections on foreign plants.
May 6, 2025
·
3 min read
·
Annalee Armstrong
VC Financings Drop 20% in Q1 but Megarounds Keep Median Deal Size High
Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first three months of this year, headlined by a clutch of massive funding rounds.
May 6, 2025
·
2 min read
·
Annalee Armstrong
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral sclerosis, coming less than a year after the pharma licensed QurAlis’ antisense oligonucleotide to correct a specific protein alteration in ALS.
May 6, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans
In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing investments in the U.S., including Eli Lilly, Johnson & Johnson and Novartis. BMS is the latest to make a multibillion-dollar push.
May 6, 2025
·
2 min read
·
Tristan Manalac
Legal
States Sue RFK Jr., Makary, Seeking To Block HHS Cuts
Twenty attorneys general allege that the recent workforce reduction at the Department of Health and Human Services is unlawful and could have potentially irreversible consequences.
May 6, 2025
·
2 min read
·
Tristan Manalac
1 of 84,658
Next
